Answers are grounded in this paper and cite their sources.
Nontumor‐specific messenger RNA may sensitize cold tumors to checkpoint blockade, but survival estimates are heterogeneous, bias‐aligned analyses reveal no difference, and spreading is unproven.
No takes yet. Share an insight, caveat, or question.
Sarfaraz K. Niazi (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: